Immunocore Holdings PLC (IMCR)
32.28
+0.16
(+0.50%)
USD |
NASDAQ |
Nov 22, 16:00
32.22
-0.06
(-0.19%)
After-Hours: 20:00
Immunocore Holdings Shareholders Equity (Quarterly): 377.83M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 377.83M |
| June 30, 2024 | 359.14M |
| March 31, 2024 | 359.53M |
| December 31, 2023 | 368.84M |
| September 30, 2023 | 355.71M |
| June 30, 2023 | 349.73M |
| March 31, 2023 | 339.47M |
| December 31, 2022 | 338.90M |
| September 30, 2022 | 329.22M |
| Date | Value |
|---|---|
| June 30, 2022 | 199.70M |
| March 31, 2022 | 214.51M |
| December 31, 2021 | 231.53M |
| September 30, 2021 | 271.07M |
| June 30, 2021 | 307.44M |
| March 31, 2021 | 337.85M |
| December 31, 2020 | 75.43M |
| September 30, 2020 | 20.00M |
| December 31, 2019 | 19.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
19.37M
Minimum
Dec 2019
377.83M
Maximum
Sep 2024
269.74M
Average
333.54M
Median
Shareholders Equity (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 79.99M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 130.49M |
| NuCana PLC | 4.806M |
| Autolus Therapeutics PLC | 476.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.085B |
| Total Liabilities (Quarterly) | 706.81M |
| Debt to Equity Ratio | 1.161 |
| Current Ratio | 3.778 |
| Net Debt Paydown Yield | -5.02% |